Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL\(^{\mathrm{pro}}\) inhibitors

DOI10.1016/J.JTBI.2008.07.030zbMATH Open1400.92196OpenAlexW2061256139WikidataQ46427243 ScholiaQ46427243MaRDI QIDQ1797730

Maturos Malaisree, Ornjira Aruksakulwong, Supot Hannongbua, Veena Nukoolkarn, Vannajan Sanghiran Lee

Publication date: 22 October 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2008.07.030

zbMATH Keywords

SARSMD simulationsproteinaselopinavirritonavir

Mathematics Subject Classification ID

Medical applications (general) (92C50) Biochemistry, molecular biology (92C40)

Related Items (2)

Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors ⋮ Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on SARS-CoV polymerase and other proteins

Recommendations

• Molecular dynamics simulation of HIV fusion inhibitor T-1249: insights on peptide-lipid interac\-tion 👍 👎
• QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors 👍 👎
• Modeling interactions between \(\mathrm{C}_{60}\) antiviral compounds and HIV protease 👍 👎
• Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors 👍 👎
• Structural analysis of inhibition mechanisms of Aurintricarboxylic Acid on SARS-CoV polymerase and other proteins 👍 👎

This page was built for publication: Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL\(^{\mathrm{pro}}\) inhibitors

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1797730)